30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Gannon, Steven

Track

Insider profile

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gannon, Steven's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-10 2025-06-05
S Sale
92,881 +12.7%
13.40
US$611,538 		92,881 +12.7% 13.40 US$611,538
2024-03-12 2024-03-07
S Sale
30,524 -30.9%
298.52
CA$435,725 		30,524 -30.9% 298.52 CA$435,725
2024-03-12 2024-03-07
S Sale
31,114 -39.3%
316.76
CA$3,339,190 		31,114 -39.3% 316.76 CA$3,339,190
2024-03-12 2024-03-07
S Sale
5,000 -35.7%
46.25
CA$231,250 		5,000 -35.7% 46.25 CA$231,250
2024-03-12 2024-03-07
S Sale
1,000 -6.7%
46.45
CA$46,450 		1,000 -6.7% 46.45 CA$46,450